Exelixis
EXEL
#1694
Rank
โ‚น1.072 T
Marketcap
โ‚น3,985
Share price
-0.02%
Change (1 day)
30.57%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Market capitalization of Exelixis (EXEL)

Market cap: โ‚น1.072 Trillion

As of December 2025 Exelixis has a market cap of โ‚น1.072 Trillion. This makes Exelixis the world's 1694th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Exelixis from 2000 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น1.072 T29.52%
2024โ‚น828.30 B33.37%
2023โ‚น621.05 B45.06%
2022โ‚น428.13 B-0.55%
2021โ‚น430.49 B-5.46%
2020โ‚น455.37 B19.28%
2019โ‚น381.78 B-7.43%
2018โ‚น412.44 B-28.18%
2017โ‚น574.27 B95.49%
2016โ‚น293.75 B243.81%
2015โ‚น85.44 B377.9%
2014โ‚น17.87 B-74.42%
2013โ‚น69.88 B52.04%
2012โ‚น45.96 B35.37%
2011โ‚น33.95 B-15.54%
2010โ‚น40.20 B8.94%
2009โ‚น36.90 B44.84%
2008โ‚น25.47 B-28.18%
2007โ‚น35.47 B-7.28%
2006โ‚น38.26 B8.22%
2005โ‚น35.35 B14.59%
2004โ‚น30.85 B34.83%
2003โ‚น22.88 B0.45%
2002โ‚น22.78 B-49.4%
2001โ‚น45.02 B41.16%
2000โ‚น31.89 B

End of Day market cap according to different sources

On Dec 5th, 2025 the market cap of Exelixis was reported to be:

โ‚น1.068 Trillion
by Nasdaq info icon info icon
โ‚น1.072 Trillion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
GlaxoSmithKline
GSK
โ‚น8.778 T 718.29%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
โ‚น10.861 T 912.40%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚น22.376 T 1,985.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น9.537 T 789.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น15.958 T 1,387.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น43.706 T 3,973.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น13.295 T 1,139.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
โ‚น1.56 B-99.85%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
โ‚น46.84 B-95.63%๐Ÿ‡บ๐Ÿ‡ธ USA